The impact of post-traumatic stress disorders on women’s reproductive function

Authors

DOI:

https://doi.org/10.18370/2309-4117.2025.78.16-21

Keywords:

female reproductive function, posttraumatic stress disorder, functional hypothalamic amenorrhea, premature ovarian insufficiency

Abstract

Objective of the study: to investigate the course of secondary amenorrhea in women with posttraumatic stress disorder (PTSD) based on the study of their hormonal and immune system.

Materials and methods. The study included 54 women of reproductive age with amenorrhea and PTSD (main group). Using enzyme-linked immunosorbent assay, the levels of prolactin, follicle-stimulating and luteinizing hormones, estradiol, progesterone, free testosterone, anti-Müllerian hormone, thyroid-stimulating hormone, free thyroxine, daily urine cortisol, as well as antibodies to thyroid peroxidase (TPOAb) and ovarian autoantibodies were determined. According to the hormonal study, the women were divided into 2 subgroups: the first subgroup included 35 (64.8%) patients with functional hypothalamic amenorrhea (FHA), the second subgroup included 19 (35.2%) women with premature ovarian insufficiency (POI). The control group consisted of 23 healthy women aged 18–37 years.

Results. It was detected a 1.5-fold increase level of prolactin in the subgroup with POI vs. control group. Significantly elevated thyroid-stimulating hormone levels were found only in the POI subgroup (21.1% vs. 0% of in the control). Ovarian antibodies were detected in 26.3% of patients with POI vs. 2.9% in women with FHA (p ˂ 0.05). The increased TPOAb levels were not detected in the subgroup of women with FHA and in the control group, but in patients with POI it was detected in 21.1% of cases. А simultaneous increase in the level of both TPOAb and ovarian antibodies was diagnosed in 10.5% of patients in the subgroup with POI.

Conclusions. Disorders of reproductive function in women with PTSD can be manifested by FHA or POI. The presence of TPOAb and ovarian antibodies IgG indicates the significant role of the immune system in the choice of the pathogenetic chain of amenorrhea development.

Author Biographies

O.H. Horbatiuk, National Pirogov Memorial Medical University. Vinnytsia

PhD, associate professor, Department of Pediatrics, Obstetrics and Gynaecology, Faculty of Postgraduate Education

O.V. Vaskiv, National Pirogov Memorial Medical University, Vinnytsia

PhD, associate professor, Department of Pediatrics, Obstetrics and Gynaecology, Faculty of Postgraduate Education

L.V. Pypa, National Pirogov Memorial Medical University, Vinnytsia

MD, professor, head of the Department of Pediatrics, Obstetrics and Gynaecology, Faculty of Postgraduate Education

I.M. Mandziy, National Pirogov Memorial Medical University, Vinnytsia

PhD, assistant professor, Department of Pediatrics, Obstetrics and Gynaecology, Faculty of Postgraduate Education

O.H. Ishchuk, Specialized Hospital in Autonomous Public Healthcare Centre, Sanok

obstetrician-gynecologist (Ukraine), medical intern

References

  1. Karlova OO, Blali FE. Endocrine and gynecological morbidity in women with infertility and post-traumatic stress disorder. Ukrainian Journal Health of Woman. 2023;5(168):14–20. DOI: 10.15574/HW.2023.168.14.
  2. Zefferino R, Di Gioia S, Conese M. Molecular links between endocrine, nervous and immune system during chronic stress. Brain Behav. 2021;11(2):e01960. DOI: 10.1002/brb3.1960.
  3. Arnold AR, Prochaska T, Fickenwirth M, et al. A systematic review on the bidirectional relationship between trauma-related psychopathology and reproductive aging. J Mood Anxiety Disord. 2024 Dec;8:100082. DOI: 10.1016/j.xjmad.2024.100082.
  4. O’Loughlin JI, Brotto LA. Women’s Sexual Desire, Trauma Exposure, and Posttraumatic Stress Disorder. J Trauma Stress. 2020 Jun;33(3):238–47. DOI: 10.1002/jts.22485.
  5. Roozitalab S, Rahimzadeh M, Mirmajidi SR, et al. The Relationship Between Infertility, Stress, and Quality of Life with Posttraumatic Stress Disorder in Infertile Women. J Reprod Infertil. 2021 Oct-Dec;22(4):282–8. DOI: 10.18502/jri.v22i4.7654.
  6. Morrison AE, Fleming S, Levy MJ. A review of the pathophysiology of functional hypothalamic amenorrhoea in women subject to psychological stress, disordered eating, excessive exercise or a combination of these factors. Clin Endocrinol (Oxf). 2021;95(2):229–38. DOI: 10.1111/cen.14399.
  7. Podfigurna A, Meczekalski B. Functional hypothalamic amenorrhea: a stress-based disease. Endocrine 2021;2: 203–11. DOI: 10.3390/endocrines2030020
  8. Merz CNB, Berga S, Cook-Weins G, et al. OR19-6 Functional Hypothalamic Amenorrhea and Preclinical Cardiovascular Disease. J Endo Soc 2022;6(1): A512. DOI: 10.1210/jendso/bvac150.512.
  9. Szeliga A, Podfigurna A, Meczekalski B. Nesfatin-1 as a potential marker for functional hypothalamic amenorrhea. Gynecol Endocrinol. 2022;38(11):992–6. DOI: 10.1080/09513590.2022.2126455.
  10. Pape J, Herbison AE, Leeners B. Recovery of menses after functional hypothalamic amenorrhoea: if, when and why. Hum Reprod Update. 2021;27(1):130–53. DOI: 10.1093/humupd/dmaa032.
  11. Szeliga A, Podfigurna A, Bala G, et al. The influence of estro-progestin therapy on neurohormonal activity in functional hypothalamic amenorrhea. Gynecol Endocrinol. 2022;38(11):997–1002. DOI: 10.1080/09513590.2022.2128103.
  12. Shatkovska AS, Hryhorenko AP, Horbatiuk OH, et al. Stress-induced disorders to the hypothalamic-hypophysal and peripheral endocrine systems in a woman’s body. Med Asp Wom Health. 2021;4(139):23–7.
  13. Shatkovska AS, Hryhorenko AP, Horbatiuk OH, et al. Features of hormonal homeostasis in women with functional hypothalamic amenorrhea and premature ovarian failure caused by post-traumatic stress disorder. Reproductive health of women 3 (2023): 65–72. DOI: 10.30841/2708-8731.3.2023.283324
  14. Chon SJ, Umair Z, Yoon MS. Premature Ovarian Insufficiency: Past, Present, and Future. Front Cell Dev Biol. 2021 May 10;9:672890. DOI: 10.3389/fcell.2021.672890.
  15. Costa GPO, Ferreira-Filho ES, Simoes RDS, et al. Impact of hormone therapy on the bone density of women with premature ovarian insufficiency: A systematic review. Maturitas. 2023 Jan;167:105–112. DOI: 10.1016/j.maturitas.2022.09.011.
  16. Jiao X, Meng T, Zhai Y, et al. Ovarian Reserve Markers in Premature Ovarian Insufficiency: Within Different Clinical Stages and Different Etiologies. Front Endocrinol (Lausanne). 2021 Mar 18;12:601752. DOI: 10.3389/fendo.2021.601752.
  17. Upton CE, Daniels JP, Davies MC. Premature ovarian insufficiency: the need for evidence on the effectiveness of hormonal therapy. Climacteric. 2021;24(5):453–8. DOI: 10.1080/13697137.2021.1902496.
  18. Gonçalves CR, Vasconcellos AS, Rodrigues TR, et al. Hormone therapy in women with premature ovarian insufficiency: a systematic review and meta-analysis. Reprod Biomed Online. 2022 Jun;44(6):1143–57. DOI: 10.1016/j.rbmo.2022.02.006.
  19. Tumurbaatar T, Kanasaki H, Cairang Z, et al. Potential role of kisspeptin in the estradiol-induced modulation of inhibin subunit gene expression: Insights from in vivo rat models and hypothalamic cell models. Endocrine Journal. 2025 May. DOI:10.1507/endocrj.EJ25-0044
  20. Meczekalski B, Niwczyk O, Bala G, Szeliga A. Stress, kisspeptin, and functional hypothalamic amenorrhea. Curr Opin Pharmacol. 2022 Dec;67:102288. DOI: 10.1016/j.coph.2022.102288.
  21. Ozawa H. Kisspeptin neurons as an integration center of reproductive regulation: Observation of reproductive function based on a new concept of reproductive regulatory nervous system. Reprod Med Biol. 2021;21(1):e12419. DOI: 10.1002/rmb2.12419.
  22. Tumurgan Z, Kanasaki H, Tumurbaatar T, et al. Roles of intracerebral activin, inhibin, and follistatin in the regulation of Kiss-1 gene expression: Studies using primary cultures of fetal rat neuronal cells. Biochem Biophys Rep. 2020;23:100785. DOI: 10.1016/j.bbrep.2020.100785
  23. Karaviti E, Karaviti D, Kani ER, et al. The role of anti-Müllerian hormone: insights into ovarian reserve, primary ovarian insufficiency, and menopause prediction. Endocrine. 2025May 23. DOI: 10.1007/s12020-025-04265-0
  24. Di Clemente N, Racine C, Pierre A, et al. Anti-müllerian hormone in female reproduction. Endocr. Rev. 42.6 (2021): 753–82. DOI: 10.1210/endrev/bnab012.
  25. Practice Committee of the American Society for Reproductive Medicine. Current evaluation of amenorrhea: a committee opinion. Fertility and Sterility. 2024. 122(1): 52–61. DOI: 10.1016/j.fertnstert.2024.02.001.
  26. De Souza MJ, Mallinson RJ, Strock NCA, et al. Randomised controlled trial of the effects of increased energy intake on menstrual recovery in exercising women with menstrual disturbances: the ‘REFUEL’ study. Hum Reprod. 2021 Jul 19;36(8):2285–97. DOI: 10.1093/humrep/deab149.

Downloads

Published

2025-06-20

How to Cite

Horbatiuk, O., Vaskiv, O., Pypa, L., Mandziy, I., & Ishchuk, O. (2025). The impact of post-traumatic stress disorders on women’s reproductive function. REPRODUCTIVE ENDOCRINOLOGY, (78), 16–21. https://doi.org/10.18370/2309-4117.2025.78.16-21

Issue

No. 78 (2025)

Section

Gynecology

License

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 International License.

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.

    1. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.